NASDAQ:CERT
Certara, Inc. Stock News
$17.06
+0.710 (+4.34%)
At Close: May 09, 2024
Certara, Inc. (CERT) Q1 2024 Earnings Call Transcript
03:56am, Wednesday, 08'th May 2024
Certara, Inc. (NASDAQ:CERT ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants David Deuchler - Investor Relations William Feehery - Chief Executive Officer John Gallagher -
Certara, Inc. (CERT) Q1 Earnings Meet Estimates
07:41pm, Tuesday, 07'th May 2024
Certara, Inc. (CERT) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.12 per share a year ago.
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
04:15pm, Tuesday, 09'th Apr 2024
PRINCETON, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024
Certara Inc. (CERT) Q4 2023 Earnings Call Transcript
09:33pm, Thursday, 29'th Feb 2024
Certara Inc. (CERT) Q4 2023 Earnings Call Transcript
Certara, Inc. (CERT) Lags Q4 Earnings Estimates
07:06pm, Thursday, 29'th Feb 2024
Certara, Inc. (CERT) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.16 per share a year ago.
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and ful
Certara Inc. (CERT) Q3 2023 Earnings Call Transcript
10:41pm, Wednesday, 08'th Nov 2023
Certara Inc. (NASDAQ:CERT ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants David Deuchler - Investor Relations William Feehery - Chief Executive Officer John Gallagh
Certara, Inc. (CERT) Q3 Earnings Meet Estimates
08:17pm, Wednesday, 08'th Nov 2023
Certara, Inc. (CERT) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.10 per share a year ago.
Circling Back On Certara
02:36pm, Tuesday, 17'th Oct 2023
Certara, Inc. provides biosimulation software and services to the biotech and biopharma industry. The company is enjoying sales growth from its software division in the mid-teen but service growth is
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
04:15pm, Wednesday, 11'th Oct 2023
PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 a
Certara to Participate in Upcoming Investor Conferences
04:15pm, Tuesday, 29'th Aug 2023
PRINCETON, N.J., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor co
Certara stock drops after biotech software company misses profit target
07:24am, Thursday, 10'th Aug 2023
Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday after the biotech software company missed Wall Street's adjusted earnings and revenue targets and said its 2023 profit wo
Certara Inc. (CERT) Q2 2023 Earnings Call Transcript
10:50pm, Wednesday, 09'th Aug 2023
Certara Inc. (NASDAQ:CERT ) Q2 2023 Results Conference Call August 9, 2023 5:00 PM ET Company Participants David Deuchler - IR William Feehery - CEO and Director John Gallagher - Chief Financial Offic
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
04:30pm, Thursday, 13'th Jul 2023
PRINCETON, N.J., July 13, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of 2023
Certara to Participate in the Jefferies Global Healthcare Conference
04:15pm, Friday, 02'nd Jun 2023
PRINCETON, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global Heal